RU2006120486A - Гидроксиалкилзамещенные пиридо-7-пиримидин-7-оны - Google Patents

Гидроксиалкилзамещенные пиридо-7-пиримидин-7-оны Download PDF

Info

Publication number
RU2006120486A
RU2006120486A RU2006120486/04A RU2006120486A RU2006120486A RU 2006120486 A RU2006120486 A RU 2006120486A RU 2006120486/04 A RU2006120486/04 A RU 2006120486/04A RU 2006120486 A RU2006120486 A RU 2006120486A RU 2006120486 A RU2006120486 A RU 2006120486A
Authority
RU
Russia
Prior art keywords
formula
compound
hydroxyalkyl
kinase
alkyl
Prior art date
Application number
RU2006120486/04A
Other languages
English (en)
Other versions
RU2348632C2 (ru
Inventor
Дейвид Майкл ГОЛДШТЕЙН (US)
Дейвид Майкл ГОЛДШТЕЙН
Original Assignee
Ф.Хоффманн-Ля Рош Аг (Ch)
Ф.Хоффманн-Ля Рош Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ф.Хоффманн-Ля Рош Аг (Ch), Ф.Хоффманн-Ля Рош Аг filed Critical Ф.Хоффманн-Ля Рош Аг (Ch)
Publication of RU2006120486A publication Critical patent/RU2006120486A/ru
Application granted granted Critical
Publication of RU2348632C2 publication Critical patent/RU2348632C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Claims (9)

1. Соединение формулы I
Figure 00000001
в которой Х1 обозначает О, С=O или S(O)n, где n равно 0, 1 или 2;
Ar1 обозначает арил или гетероарил;
R1 обозначает алкоксиалкил, алкил, циклоалкил, циклоалкилалкил, гетероциклил, гидроксиалкил или гидроксициклоалкил; и
R2 обозначает гидроксиалкил, оксоалкил или гидроксициклоалкил.
2. Соединение формулы I по п.1, имеющее формулу II
Figure 00000002
в которой m равно от 0 до 4;
все R3 обозначают алкил, галоген, алкоксигруппу или галогеналкил; и
R1 и R2 являются такими, как определено в п.1.
3. Соединение по п.1, предназначенное для применения в качестве терапевтически активного вещества.
4. Способ получения соединения формулы I по п.1, включающий реакцию соединения формулы If
Figure 00000003
в которой R обозначает C16алкил, а X1, Ar1 и R2 имеют значения, определенные в п.1, с амином формулы R1-NH2.
5. Соединение формулы I по п.1, полученное способом по п.4.
6. Применение соединения формулы I по п.1 для приготовления лекарственного средства, предназначенного для борьбы с нарушением, опосредуемым киназой р38, или его предупреждения.
7. Композиция, содержащая фармацевтически приемлемый наполнитель и соединение формулы I по п.1.
8. Способ лечения нарушения, опосредуемого киназой р38, включающий введение пациенту терапевтически эффективного количества соединения по п.1.
9. Способ по п.8, в котором указанное нарушение, опосредуемое киназой р38, представляет собой артрит, болезнь Крона, синдром раздраженной толстой кишки, респираторный дистресс-синдром взрослых, хроническое обструктивное заболевание легких или болезнь Альцгеймера.
RU2006120486/04A 2003-11-13 2004-11-04 Гидроксиалкилзамещенные пиридо-7-пиримидин-7-оны RU2348632C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51978903P 2003-11-13 2003-11-13
US60/519,789 2003-11-13

Publications (2)

Publication Number Publication Date
RU2006120486A true RU2006120486A (ru) 2008-01-20
RU2348632C2 RU2348632C2 (ru) 2009-03-10

Family

ID=34590444

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006120486/04A RU2348632C2 (ru) 2003-11-13 2004-11-04 Гидроксиалкилзамещенные пиридо-7-пиримидин-7-оны

Country Status (27)

Country Link
US (2) US7348331B2 (ru)
EP (1) EP1685131B1 (ru)
JP (1) JP4616839B2 (ru)
KR (1) KR100816321B1 (ru)
CN (1) CN100455582C (ru)
AR (1) AR046705A1 (ru)
AT (1) ATE356124T1 (ru)
AU (1) AU2004289428B2 (ru)
BR (1) BRPI0416030A (ru)
CA (1) CA2544247A1 (ru)
CO (1) CO5690600A2 (ru)
DE (1) DE602004005238T2 (ru)
DK (1) DK1685131T3 (ru)
ES (1) ES2281843T3 (ru)
HK (1) HK1099021A1 (ru)
HR (1) HRP20070132T3 (ru)
IL (1) IL175284A0 (ru)
MY (1) MY141011A (ru)
NO (1) NO20062256L (ru)
NZ (1) NZ546634A (ru)
PL (1) PL1685131T3 (ru)
PT (1) PT1685131E (ru)
RU (1) RU2348632C2 (ru)
SI (1) SI1685131T1 (ru)
TW (1) TWI349670B (ru)
WO (1) WO2005047284A1 (ru)
ZA (1) ZA200603829B (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11078199B2 (en) 2014-02-07 2021-08-03 Principia Biopharma, Inc. Quinolone derivatives as fibroblast growth factor receptor inhibitors

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7935709B2 (en) 2006-07-17 2011-05-03 Amgen Inc. 2-quinazolinone compounds and methods of use
EP2097370A2 (en) * 2006-12-22 2009-09-09 F. Hoffmann-Roche AG Compounds and methods for amino-alkylenediol synthesis
CA2690327A1 (en) * 2007-06-15 2008-12-18 Thomas P. Cleary A novel process for the preparation of 3-amino-pentan-1,5-diol
US8889696B2 (en) * 2009-12-18 2014-11-18 Temple University—Of the Commonwealth System of Higher Education Substituted pyrido[2,3-d]pyrimidin-7(8H)-ones and therapeutic uses thereof
JP6940480B2 (ja) 2015-08-11 2021-09-29 プリンシピア バイオファーマ インコーポレイテッド Fgfr阻害剤の合成方法
CN105418609B (zh) * 2015-12-31 2017-06-23 山东大学 4‑(1,2,3‑三氮唑取代苯胺基)‑吡啶骈嘧啶酮衍生物及其制备方法与应用
US20190060286A1 (en) 2016-02-29 2019-02-28 University Of Florida Research Foundation, Incorpo Chemotherapeutic Methods
AU2017274442B2 (en) 2016-06-02 2021-08-19 Abbvie Inc. Glucocorticoid receptor agonist and immunoconjugates thereof
HUE053648T2 (hu) 2016-06-08 2021-07-28 Support Venture Gmbh Gyógyászati kombinációk rák kezelésére
EP3500258A1 (en) 2016-08-17 2019-06-26 Support-Venture GmbH Method of preventing or treating hearing loss
SG10202110804WA (en) 2017-04-04 2021-11-29 Kinarus Ag Methods of preventing or treating ophthalmic diseases
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
PT3691620T (pt) 2017-10-05 2022-10-06 Fulcrum Therapeutics Inc Os inibidores da quinase p38 reduzem a expressão de dux4 e genes a jusante para o tratamento de fshd
EP3884962A1 (en) 2017-12-01 2021-09-29 AbbVie Inc. Glucocorticoid receptor agonist and immunoconjugates thereof
EP3797107B1 (en) 2018-05-21 2022-08-10 Nerviano Medical Sciences S.r.l. Heterocondensed pyridone compounds and their use as idh inhibitors
MA53114A (fr) 2018-07-13 2021-05-19 Kinarus Ag Combinaisons d'agonistes de ppar et d'inhibiteurs de kinase p38 pour prévenir ou traiter des maladies fibrotiques
US20230000871A1 (en) 2019-11-08 2023-01-05 Nerviano Medical Sciences S.R.L. Gem-disubstituted heterocyclic compounds and their use as idh inhibitors
US20230263803A1 (en) 2020-08-11 2023-08-24 Kinarus Ag Methods of preventing or treating covid-19 and related viral diseases or disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215216A (en) 1979-04-18 1980-07-29 American Home Products Corporation 7,8-Dihydro-2,5,8-trisubstituted-7-oxo-pyrido[2,3-d]pyrimidine-6-carboxylic acid derivatives
US5037826A (en) 1986-10-15 1991-08-06 Schering Corporation 1-substituted naphthyridine and pyridopyrazine derivatives
AU598093B2 (en) 1987-02-07 1990-06-14 Wellcome Foundation Limited, The Pyridopyrimidines, methods for their preparation and pharmaceutical formulations thereof
WO1993017682A1 (en) 1992-03-04 1993-09-16 Abbott Laboratories Angiotensin ii receptor antagonists
IL115256A0 (en) 1994-11-14 1995-12-31 Warner Lambert Co 6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
ES2146782T3 (es) 1994-11-14 2000-08-16 Warner Lambert Co 6-aril-pirido(2,3-d)pirimidinas y naftiridinas para la inhibicion de la proliferacion celular inducida por la proteina tirosina quinasa.
IL117923A (en) 1995-05-03 2000-06-01 Warner Lambert Co Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
US5620981A (en) 1995-05-03 1997-04-15 Warner-Lambert Company Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
ATE391719T1 (de) 1997-02-05 2008-04-15 Warner Lambert Co Pyrido (2,3-d) pyrimidine und 4-amino-primidine als inhibitoren der zellulären proliferation
US5945422A (en) 1997-02-05 1999-08-31 Warner-Lambert Company N-oxides of amino containing pyrido 2,3-D! pyrimidines
AU763839B2 (en) 1998-05-26 2003-07-31 Warner-Lambert Company Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
US7053070B2 (en) 2000-01-25 2006-05-30 Warner-Lambert Company Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors
BR0017075A (pt) 2000-01-27 2002-11-05 Warner Lambert Co Derivados de piridopirimidinona para tratamento de doença neurodegenerativa
WO2001070741A1 (en) 2000-03-06 2001-09-27 Warner-Lambert Company 5-alkylpyrido[2,3-d]pyrimidines tyrosine kinase inhibitors
US6518276B2 (en) 2000-08-31 2003-02-11 Syntex (U.S.A.) Llc 7-oxo-pyridopyrimidines (II)
CA2420286A1 (en) * 2000-08-31 2002-03-07 F. Hoffmann-La Roche Ag 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation
IL156872A0 (en) * 2001-02-12 2004-02-08 Hoffmann La Roche 6-substituted pyrido-pyrimidines
DK1470124T3 (da) * 2002-01-22 2006-04-18 Warner Lambert Co 2-(Pyridin-2-yl amino)-pyrido[2,3]pyrimidin-7-oner
FR2897336B1 (fr) 2006-02-10 2010-07-30 Ranger France Support d'aile pour vehicule automobile

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11078199B2 (en) 2014-02-07 2021-08-03 Principia Biopharma, Inc. Quinolone derivatives as fibroblast growth factor receptor inhibitors

Also Published As

Publication number Publication date
HRP20070132T3 (en) 2007-05-31
CA2544247A1 (en) 2005-05-26
NO20062256L (no) 2006-06-06
TW200526657A (en) 2005-08-16
CN100455582C (zh) 2009-01-28
US7348331B2 (en) 2008-03-25
DE602004005238D1 (de) 2007-04-19
AU2004289428A1 (en) 2005-05-26
EP1685131A1 (en) 2006-08-02
PT1685131E (pt) 2007-05-31
HK1099021A1 (en) 2007-08-03
IL175284A0 (en) 2006-09-05
AR046705A1 (es) 2005-12-21
EP1685131B1 (en) 2007-03-07
CN1882585A (zh) 2006-12-20
JP2007510686A (ja) 2007-04-26
DE602004005238T2 (de) 2007-11-08
KR100816321B1 (ko) 2008-03-24
US20050107408A1 (en) 2005-05-19
MY141011A (en) 2010-02-25
ZA200603829B (en) 2007-10-31
AU2004289428B2 (en) 2010-06-03
KR20060086417A (ko) 2006-07-31
BRPI0416030A (pt) 2007-01-02
RU2348632C2 (ru) 2009-03-10
US20080119497A1 (en) 2008-05-22
ATE356124T1 (de) 2007-03-15
WO2005047284A1 (en) 2005-05-26
NZ546634A (en) 2010-01-29
US7750016B2 (en) 2010-07-06
PL1685131T3 (pl) 2007-08-31
SI1685131T1 (sl) 2007-06-30
ES2281843T3 (es) 2007-10-01
TWI349670B (en) 2011-10-01
JP4616839B2 (ja) 2011-01-19
CO5690600A2 (es) 2006-10-31
DK1685131T3 (da) 2007-07-09

Similar Documents

Publication Publication Date Title
RU2006120486A (ru) Гидроксиалкилзамещенные пиридо-7-пиримидин-7-оны
RU2006134020A (ru) Конденсированные производные пиразола
RU2324684C2 (ru) Пиримидиновые производные
JP2020183410A5 (ru)
RU2007130144A (ru) Гетероциклические соединения в качестве антагонистов cccr2b
JP2017533968A5 (ru)
RU2008127750A (ru) Антивирусные нуклеозиды
RU2002123350A (ru) Дипептиднитрильные ингибиторы катепсина К
JP2018535967A5 (ru)
JP2004528312A5 (ru)
JP2008513498A5 (ru)
RU2007128987A (ru) 3,4-дигидро-1н-изохинолин-2-карбоновой кислоты 5-аминопиридин-2-2-иловые эфиры
JP2013010792A5 (ru)
JP2008509187A5 (ru)
TW201623265A (zh) 抗病毒化合物、醫藥組合物及其使用方法
RU2006130000A (ru) Органические соединения
RU2005128190A (ru) Ингибиторы фактора подавления миграции макрофагов (фпм) и способы их идентификации
RU2005106202A (ru) 6-алкоксипиридопиримидины в качестве ингибиторов киназы мар р-38
JP2009504763A5 (ru)
RU2011117927A (ru) Карбаматное соединение или его соль
RU2010145463A (ru) Производные замещенного 2-фенилпиридина
RU2006134022A (ru) Производные индазола и содержащие их фармацевтические композиции
JP2016503785A5 (ru)
JP2019519616A5 (ru)
RU2009118254A (ru) Фенилацетамиды в качестве ингибиторов протеинкиназ

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20121105